Find-A-Study

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis

Purpose

Category

Lungs, Breathing and Bronchial

IRB Number: 20220305HU
NCT Number: -
Sponsor: -

Study Contact

Principal Investigator
Anoop Nambiar

Omar Allen
210-450-9098
alleno@uthscsa.edu

Darcy Bair Kelps
210-450-9098
bairkelps@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups